Fidelity Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75B | Sell |
|
|||||
|
2025
Q1 | $4.82B | Sell |
|
|||||
|
2024
Q4 | $5.84B | Sell |
|
|||||
|
2024
Q3 | $10.9B | Sell |
|
|||||
|
2024
Q2 | $11.2B | Sell |
|
|||||
|
2024
Q1 | $10.4B | Buy |
|
|||||
|
2023
Q4 | $9.06B | Buy |
|
|||||
|
2023
Q3 | $8.1B | Buy |
|
|||||
|
2023
Q2 | $6.59B | Sell |
|
|||||
|
2023
Q1 | $7.76B | Sell |
|
|||||
|
2022
Q4 | $8.01B | Buy |
|
|||||
|
2022
Q3 | $7.45B | Buy |
|
|||||
|
2022
Q2 | $6.02B | Buy |
|
|||||
|
2022
Q1 | $6.97B | Sell |
|
|||||
|
2021
Q4 | $6.35B | Sell |
|
|||||
|
2021
Q3 | $6.7B | Buy |
|
|||||
|
2021
Q2 | $6.09B | Sell |
|
|||||
|
2021
Q1 | $5.17B | Sell |
|
|||||
|
2020
Q4 | $5.55B | Sell |
|
|||||
|
2020
Q3 | $7.12B | Buy |
|
|||||
|
2020
Q2 | $7.77B | Buy |
|
|||||
|
2020
Q1 | $4.13B | Buy |
|
|||||
|
2019
Q4 | $1.21B | Buy |
|
|||||
|
2019
Q3 | $758M | Sell |
|
|||||
|
2019
Q2 | $1B | Sell |
|
|||||
|
2019
Q1 | $1.82B | Sell |
|
|||||
|
2018
Q4 | $2B | Buy |
|
|||||
|
2018
Q3 | $2.03B | Buy |
|
|||||
|
2018
Q2 | $1.48B | Sell |
|
|||||
|
2018
Q1 | $1.79B | Sell |
|
|||||
|
2017
Q4 | $2.12B | Sell |
|
|||||
|
2017
Q3 | $3.13B | Sell |
|
|||||
|
2017
Q2 | $3.46B | Buy |
|
|||||
|
2017
Q1 | $2.57B | Sell |
|
|||||
|
2016
Q4 | $2.87B | Sell |
|
|||||
|
2016
Q3 | $3.67B | Sell |
|
|||||
|
2016
Q2 | $3.29B | Buy |
|
|||||
|
2016
Q1 | $3.11B | Buy |
|
|||||
|
2015
Q4 | $3.38B | Buy |
|
|||||
|
2015
Q3 | $2.61B | Sell |
|
|||||
|
2015
Q2 | $3.03B | Sell |
|
|||||
|
2015
Q1 | $2.71B | Sell |
|
|||||
|
2014
Q4 | $2.74B | Buy |
|
|||||
|
2014
Q3 | $2.15B | Buy |
|
|||||
|
2014
Q2 | $1.49B | Sell |
|
|||||
|
2014
Q1 | $1.72B | Sell |
|
|||||
|
2013
Q4 | $1.99B | Sell |
|
|||||
|
2013
Q3 | $2.8B | Sell |
|
|||||
|
2013
Q2 | $2.32B | Buy |
|